| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1025151S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0125151 |
| P8608 | Fatcat ID | release_s3eqfrfyj5gbvp5pdkxpnfqbzq |
| P932 | PMC publication ID | 4412567 |
| P698 | PubMed publication ID | 25919866 |
| P5875 | ResearchGate publication ID | 276127061 |
| P2093 | author name string | Hongmei Zhang | |
| Anna Woloszynska-Read | |||
| Susan E Steck | |||
| James L Mohler | |||
| Candace S Johnson | |||
| Donald L Trump | |||
| Lenore Arab | |||
| Jeannette T Bensen | |||
| Gary J Smith | |||
| Elizabeth T H Fontham | |||
| Joseph L Su | |||
| P2860 | cites work | Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry | Q22306429 |
| Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans | Q24651976 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types | Q28182423 | ||
| A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer | Q28221539 | ||
| The prevalence of hypovitaminosis D among US adults: data from the NHANES III. | Q31021602 | ||
| Plasma vitamin D and mortality in older men: a community-based prospective cohort study | Q33447581 | ||
| Vitamin D-binding protein and vitamin D status of black Americans and white Americans | Q33647671 | ||
| Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort | Q33712468 | ||
| Vitamin D deficiency predicts prostate biopsy outcomes | Q33923335 | ||
| Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease | Q33983615 | ||
| Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial | Q33992150 | ||
| Skin pigmentation, biogeographical ancestry and admixture mapping | Q34176523 | ||
| Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial | Q34206945 | ||
| Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort | Q34221111 | ||
| Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade | Q34228158 | ||
| Implications of correlations between skin color and genetic ancestry for biomedical research. | Q34362378 | ||
| Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies | Q34413128 | ||
| Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). | Q34741311 | ||
| High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates | Q34890877 | ||
| Vitamin D-related therapies in prostate cancer | Q35016885 | ||
| Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression | Q35042220 | ||
| Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study | Q35286318 | ||
| Vitamin D and prostate cancer prevention and treatment | Q35569014 | ||
| Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study | Q35925515 | ||
| Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer | Q36197698 | ||
| Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study | Q36245592 | ||
| Sunlight and other determinants of circulating 25-hydroxyvitamin D levels in black and white participants in a nationwide U.S. study | Q36661771 | ||
| Predictors of serum vitamin D levels in African American and European American men in Chicago | Q36919008 | ||
| Vitamin D signalling pathways in cancer: potential for anticancer therapeutics | Q36919979 | ||
| Serum vitamin D concentration and prostate cancer risk: a nested case-control study | Q36989937 | ||
| Vitamin D and cancer incidence in the Harvard cohorts | Q37091386 | ||
| Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) | Q37175475 | ||
| Mapping cancer mortality-to-incidence ratios to illustrate racial and sex disparities in a high-risk population | Q37208485 | ||
| Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs | Q37238604 | ||
| Vitamin D and prostate cancer risk: a review of the epidemiological literature | Q37435932 | ||
| Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study | Q37681134 | ||
| Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. | Q37825803 | ||
| Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study | Q38432079 | ||
| Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States) | Q41676131 | ||
| Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). | Q42288511 | ||
| Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. | Q42733565 | ||
| Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial | Q42766017 | ||
| Ethnic differences in the nutrient intake adequacy of premenopausal US women: results from the Third National Health Examination Survey | Q43643746 | ||
| Ultraviolet index and racial differences in prostate cancer incidence and mortality | Q44411708 | ||
| Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries | Q44656380 | ||
| Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men. | Q46204609 | ||
| Differences in vitamin-D status may explain black-white differences in breast cancer survival rates. | Q46354219 | ||
| Population distribution of the human vitamin D binding protein: anthropological considerations | Q46429090 | ||
| Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. | Q46845342 | ||
| The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes | Q46950336 | ||
| Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer | Q47747682 | ||
| Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. | Q53062495 | ||
| Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. | Q53367159 | ||
| Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States) | Q56087786 | ||
| Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study | Q57191881 | ||
| Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III | Q64128190 | ||
| Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein | Q69593309 | ||
| Circulating vitamin D metabolites in relation to subsequent development of prostate cancer | Q71637475 | ||
| Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) | Q73183645 | ||
| Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system | Q74029916 | ||
| Vitamin D intakes by children and adults in the United States differ among ethnic groups | Q81246049 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0125151 | |
| P577 | publication date | 2015-04-28 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP | |
| P478 | volume | 10 |
| Q47440388 | An update of research evidence on nutrition and prostate cancer |
| Q91938922 | Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness |
| Q37628321 | Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men. |
| Q40845563 | Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES |
| Q36915269 | Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy |
| Q49540308 | Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies |
| Q40894878 | DNA methylation profiles in African American prostate cancer patients in relation to disease progression |
| Q92576725 | High levels of PIWI-interacting RNAs are present in the small RNA landscape of prostate epithelium from vitamin D clinical trial specimens |
| Q36264367 | Prostatic compensation of the vitamin D axis in African American men. |
| Q38401811 | Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men. |
| Q38795645 | Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges |
Search more.